AOCI at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s AOCI?
- Xeris Biopharma Holdings, Inc. (XERS) reported AOCI of -$24K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s AOCI changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s AOCI increased by 4.0% year-over-year, from -$25K to -$24K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s AOCI has grown at a 33.0% compound annual growth rate (CAGR), from $6K to -$25K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.